Immunic Stock Market Value
| IMUX Stock | USD 1.11 0.02 1.77% |
| Symbol | Immunic |
Immunic Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. If investors know Immunic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Return On Assets (0.91) | Return On Equity (2.16) |
The market value of Immunic is measured differently than its book value, which is the value of Immunic that is recorded on the company's balance sheet. Investors also form their own opinion of Immunic's value that differs from its market value or its book value, called intrinsic value, which is Immunic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunic's market value can be influenced by many factors that don't directly affect Immunic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunic.
| 11/16/2024 |
| 12/16/2024 |
If you would invest 0.00 in Immunic on November 16, 2024 and sell it all today you would earn a total of 0.00 from holding Immunic or generate 0.0% return on investment in Immunic over 30 days. Immunic is related to or competes with Generation Bio, Kronos Bio, Erasca, C4 Therapeutics, Edgewise Therapeutics, Foghorn Therapeutics, and Shattuck Labs. Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies fo... More
Immunic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunic upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 23.75 | |||
| Value At Risk | (6.84) | |||
| Potential Upside | 7.27 |
Immunic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunic's standard deviation. In reality, there are many statistical measures that can use Immunic historical prices to predict the future Immunic's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | (0.90) | |||
| Treynor Ratio | (0.24) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunic Backtested Returns
Immunic holds Efficiency (Sharpe) Ratio of -0.0989, which attests that the entity had a -0.0989% return per unit of risk over the last 3 months. Immunic exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunic's Market Risk Adjusted Performance of (0.23), standard deviation of 4.7, and Risk Adjusted Performance of (0.04) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.34, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immunic will likely underperform. At this point, Immunic has a negative expected return of -0.46%. Please make sure to check out Immunic's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Immunic performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.7 |
Very good reverse predictability
Immunic has very good reverse predictability. Overlapping area represents the amount of predictability between Immunic time series from 16th of November 2024 to 1st of December 2024 and 1st of December 2024 to 16th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunic price movement. The serial correlation of -0.7 indicates that around 70.0% of current Immunic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.7 | |
| Spearman Rank Test | -0.79 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Immunic lagged returns against current returns
Autocorrelation, which is Immunic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immunic's stock expected returns. We can calculate the autocorrelation of Immunic returns to help us make a trade decision. For example, suppose you find that Immunic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immunic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immunic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immunic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immunic stock over time.
Current vs Lagged Prices |
| Timeline |
Immunic Lagged Returns
When evaluating Immunic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immunic stock have on its future price. Immunic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immunic autocorrelation shows the relationship between Immunic stock current value and its past values and can show if there is a momentum factor associated with investing in Immunic.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immunic Stock Analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.